Literature DB >> 8613363

Colony-stimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis.

W Wiktor-Jedrzejczak1, B Dzwigala, M Szperl, M Maruszynski, E Urbanowska, P Szwech.   

Abstract

Osteopetrotic op/op mice have less than 5% of the normal number of macrophages in the peritoneal cavity (W. Wiktor-Jedrzejczak, A. Ahmed, C. Szczylik, and R.R. Skelly, J. Exp. Med. 156:1516-1527, 1982). Fecal peritonitis was induced by intraperitoneal injection of 0.5 ml of 5% autoclaved feces in saline along with Escherichia coli grown from feces of mice of the same colony and added in doses ranging between 10 and 10(6) CFU. Such infection led to a septic shock and either was lethal within 24 h or became cured without additional treatment of the mice. The op/op mice survived administration of 30-times-smaller doses of bacteria compared with their normal littermates. Analysis of the kinetics of cellular changes in the peritoneal cavity associated with such infection revealed that this increased susceptibility of macrophage-deficient mice cannot be explained by a direct role of macrophages in combating the infection. Instead, it appeared that the increased susceptibility to fatal fecal peritonitis was most likely due to delayed and impaired recruitment of neutrophils to the site of infection in mutant mice. The increased susceptibility of the op/op mice to E. coli fecal peritonitis was not due to their possible increased sensitivity to endotoxin, since the mutant mice tolerated lipopolysaccharide doses more than twice those tolerated by control littermates. On the other hand, their susceptibility to exogenous tumor necrosis factor alpha and interleukin-1 alpha was increased. Both mutant op/op and control mice were able to survive secondary challenge with 10(6) E. coli (administered along with feces) lethal for both types of mice on primary challenge. These data suggest that colony-stimulating factor 1-dependent resident peritoneal macrophages play a role in controlling primary infection by recruiting neutrophils and are not required for efficient response to secondary infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613363      PMCID: PMC173964          DOI: 10.1128/iai.64.5.1577-1581.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.

Authors:  W Wiktor-Jedrzejczak; A Bartocci; A W Ferrante; A Ahmed-Ansari; K W Sell; J W Pollard; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Factors influencing the outcome of E. coli peritonitis in rats.

Authors:  R Andersson; K G Tranberg; A Alwmark; S Bengmark
Journal:  Acta Chir Scand       Date:  1989-03

4.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

5.  Pathogenicity of enterococci in a rat model of fecal peritonitis.

Authors:  A G Matlow; J M Bohnen; C Nohr; N Christou; J Meakins
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

6.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

7.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

8.  Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor.

Authors:  M Naito; S Hayashi; H Yoshida; S Nishikawa; L D Shultz; K Takahashi
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

9.  Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor.

Authors:  W Wiktor-Jedrzejczak; E Urbanowska; S L Aukerman; J W Pollard; E R Stanley; P Ralph; A A Ansari; K W Sell; M Szperl
Journal:  Exp Hematol       Date:  1991-11       Impact factor: 3.084

10.  Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation.

Authors:  W W Wiktor-Jedrzejczak; A Ahmed; C Szczylik; R R Skelly
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more
  4 in total

1.  Colony-stimulating factor 1-dependent cells protect against systemic infection with Listeria monocytogenes but facilitate neuroinvasion.

Authors:  Yuxuan Jin; Lone Dons; Krister Kristensson; Martin E Rottenberg
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Evaluation of macrophage plasticity in brown and white adipose tissue.

Authors:  M Teresa Ortega; Linglin Xie; Silvia Mora; Stephen K Chapes
Journal:  Cell Immunol       Date:  2011-06-23       Impact factor: 4.868

3.  Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents.

Authors:  Sven Wehner; Florian F Behrendt; Boris N Lyutenski; Mariola Lysson; Anthony J Bauer; Andreas Hirner; Jörg C Kalff
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

4.  Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1-deficient mice.

Authors:  I Guleria; J W Pollard
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.